Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Catalysts Track record Movers The Lead Compound

Home › Targets › EGFR L858R

EGFR L858R (1 companies · 1 programs)

Companies with an active program directed at EGFR L858R.

C4 Therapeutics, Inc. CCCC

CFT8919 — Non-Small Cell Lung Cancer Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.